Company Filing History:
Years Active: 2013-2015
Title: John Lu: Innovator in Biotherapeutics
Introduction
John Lu is a notable inventor based in Culver City, CA (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of receptor polypeptides that have potential applications in treating muscle-wasting diseases.
Latest Patents
John Lu holds 2 patents related to his innovative work. His latest patents include "Variant activin receptor polypeptides and uses thereof." This invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. Additionally, the invention encompasses polynucleotides, vectors, and host cells capable of producing these variant polypeptides and proteins. Compositions and methods for treating muscle-wasting and other diseases and disorders are also included in this patent.
Career Highlights
Throughout his career, John Lu has worked with prominent companies in the biopharmaceutical industry. Notable among these are Amgen Inc. and Atara Biotherapeutics, Inc. His work in these organizations has contributed to advancements in therapeutic solutions.
Collaborations
John Lu has collaborated with several professionals in his field, including Jeonghoon Sun and Lei-Ting Tony Tam. These collaborations have likely enhanced the scope and impact of his inventions.
Conclusion
John Lu's innovative work in receptor polypeptides showcases his commitment to advancing biotherapeutics. His contributions have the potential to significantly impact the treatment of muscle-wasting diseases and other disorders.